Allergy Therapeutics PLC (AGYTF)
0.02
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Allergy Therapeutics Total Assets (Quarterly): 88.00M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.00M |
| December 31, 2023 | 88.00M |
| June 30, 2023 | 84.22M |
| December 31, 2022 | 86.66M |
| December 31, 2022 | 86.66M |
| June 30, 2022 | 88.48M |
| December 31, 2021 | 124.13M |
| December 31, 2021 | 124.13M |
| June 30, 2021 | 121.92M |
| December 31, 2020 | 134.92M |
| December 31, 2020 | 134.92M |
| June 30, 2020 | 106.13M |
| December 31, 2019 | 115.28M |
| December 31, 2019 | 115.28M |
| June 30, 2019 | 86.80M |
| December 31, 2018 | 90.44M |
| December 31, 2018 | 90.44M |
| June 30, 2018 | 66.70M |
| December 31, 2017 | 87.71M |
| December 31, 2017 | 87.71M |
| June 30, 2017 | 74.40M |
| December 31, 2016 | 79.68M |
| December 31, 2016 | 79.68M |
| June 30, 2016 | 76.30M |
| December 31, 2015 | 95.40M |
| Date | Value |
|---|---|
| December 31, 2015 | 95.40M |
| June 30, 2015 | 79.72M |
| December 31, 2014 | 55.50M |
| December 31, 2014 | 55.50M |
| June 30, 2014 | 48.37M |
| December 31, 2013 | 56.33M |
| December 31, 2013 | 56.33M |
| June 30, 2013 | 44.18M |
| December 31, 2012 | 53.34M |
| December 31, 2012 | 53.34M |
| June 30, 2012 | 43.06M |
| December 31, 2011 | 50.96M |
| December 31, 2011 | 50.96M |
| June 30, 2011 | 49.22M |
| December 31, 2010 | 52.75M |
| June 30, 2010 | 43.50M |
| December 31, 2009 | 54.18M |
| June 30, 2009 | 36.35M |
| December 31, 2008 | 41.96M |
| June 30, 2008 | 46.20M |
| December 31, 2007 | 54.01M |
| June 30, 2007 | 48.18M |
| December 31, 2006 | 63.93M |
| June 30, 2006 | 70.01M |
| December 31, 2005 | 41.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
84.22M
Minimum
Jun 2023
134.92M
Maximum
Dec 2020
105.70M
Average
106.13M
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 258.01M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Verona Pharma PLC | 289.91M |
| NuCana PLC | 31.31M |
| Autolus Therapeutics PLC | 901.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 54.29M |
| Shareholders Equity (Quarterly) | 33.71M |
| Debt to Equity Ratio | 0.0598 |
| Current Ratio | 1.399 |
| Net Debt Paydown Yield | 0.67% |